Daytrana and product quality issue Patient Reports February 13, 2012

Daytrana Side Effects Report #6103607-9
Daytrana side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2009. Female patient, child 9 years of age, weighting 74.96 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site bleeding, application site dermatitis, application site erythema, device failure, product quality issue, suicide attempt. Daytrana dosage: 20 MG, 1X/DAY:QD, TRANSDERMAL. During the same period patient was treated with ZOLOFT. Patient recovered.

Daytrana Side Effects Report #6059687-2
Daytrana side effect was reported by a Physician from UNITED STATES on Jan 23, 2009. Male patient, child 6 years of age, weighting 42.99 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: product quality issue, salmonellosis. Daytrana dosage: 10 MG, 1X/DAY:QD, TRANSDERMAL. During the same period patient was treated with NUTROPIN. Patient was hospitalized. Patient recovered.

Daytrana Side Effects Report #5999094-1
Daytrana side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 26, 2008. Female patient, child 5 years of age, weighting 46.08 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: ear infection , insomnia, off label use, pneumonia , product quality issue. Daytrana dosage: 10 MG, 1X/DAY;QD, TRANSDERMAL. During the same period patient was treated with SINGULAIR, PULMICORT, ZOVINOX, CLARITIN. Patient recovered.

Daytrana Side Effects Report #6016769-9
Daytrana side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 02, 2008. Female patient, child 11 years of age, weighting 104.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: application site rash, product quality issue, scarlet fever, weight decreased. Daytrana dosage: 20 MG, 1X/DAY:QD, TRANSDERMAL. During the same period patient was treated with SINGULAIR, NASONEX, PEPCID. Patient recovered.


Daytrana Side Effects Report #5989365-7
Daytrana side effect was reported by a Pharmacist from UNITED STATES on Nov 21, 2008. Male patient was treated with Daytrana. After drug was administered, patient experienced the following side effects: adverse event, condition aggravated, crohn's disease , device failure, off label use, product quality issue. Daytrana dosage: unknown. During the same period patient was treated with PREDNISONE, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.